ew therapeutic approach to Tourette Syndrome in children based on a study of the effectiveness and safety of magnesium and vitamin B6

Completed

• Conditions: Tourette Syndrome; Mental and Behavioural Disorders; Tic disorders

• Registration Number: ISRCTN41082378
• Lead Sponsor: The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09-30
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

1. Aged 7 - 14 years, either sex. This is the age bracket during which the natural course of the illness is most exacerbated. Before the age of 7 years, the tics may not yet have appeared (this generally occurs at the age of 5 - 7 years). After 14 years, symptoms tend to stabilise.
2. Informed consent of the child's parents or guardians, and reasoned agreement with the child
3. Clinical diagnosis of TS, according to Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) criteria
4. Score of 40 or more on the YGTSS

Exclusion Criteria

1. Severe attention deficit hyperactivity disorder (ADHD) or obsessive compulsive disorder (OCD), not clinically controlled
2. Autism
3. Unrelated depression
4. Allergy to acetylsalicylic acid (due to the excipients used)

Study & Design

• Study Type: Interventional
• Study Design: Not specified